Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
Amount Raised
$25 Million
Round Type
Series B
MiltonBiotechnologyTherapeuticsInvestors
Description
Pathios Therapeutics Limited has raised $25 million in the first close of a Series B financing. The fundraising includes a new strategic investment by Bristol Myers Squibb, along with continued support from existing investors including Canaan and Brandon Capital. The proceeds will be used to advance their lead candidate, PTT-4256, into the clinic and expand their leadership team to align with their transition into a clinical-stage company.
Quick answer
Pathios Therapeutics raised $25 Million in a Series B round, dated April 19, 2024. Investors: Brandon Capital, Canaan and Bristol Myers Squibb. Pathios Therapeutics is based in Milton, Oxfordshire, United Kingdom.
- How much did Pathios Therapeutics raise?
- Pathios Therapeutics raised $25 Million in a Series B round on April 19, 2024.
- Who invested in Pathios Therapeutics?
- Brandon Capital, Canaan and Bristol Myers Squibb are named as investors in this round.
- What does Pathios Therapeutics do?
- Pathios Therapeutics is an early-stage drug discovery company that was established in 2017 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs.
- Where is Pathios Therapeutics based and how big is it?
- Pathios Therapeutics is based in Milton, Oxfordshire, United Kingdom.
- Who are the decision-makers at Pathios Therapeutics?
- Fundz holds 1 contact at Pathios Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Pathios Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Aptose Biosciences raised $4.4M (Seed) on June 3, 2024.
- Calidi Biotherapeutics raised $5.5M on June 3, 2024.
- Summit Therapeutics raised $200M on June 3, 2024.
- Sinopia Biosciences raised an undisclosed amount (Grant) on May 30, 2024.
- Radiomer Therapeutics raised an undisclosed amount (Pre-Seed) on May 29, 2024.
- SystImmune raised $7.2M on May 28, 2024.
Who to call at Pathios Therapeutics, and when
A new round usually means Pathios Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pathios Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pathios Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pathios Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pathios Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPathios Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.